Paeds · respiratory-sleep-and-airway
Narcolepsy and hypersomnolence
Also known as Narcolepsy · Narcolepsy type 1 · Narcolepsy type 2 · Narcolepsy with cataplexy · Narcolepsy without cataplexy · Cataplexy · Hypersomnolence · Central disorders of hypersomnolence · Idiopathic hypersomnia · Excessive daytime sleepiness · Hypocretin deficiency · Orexin deficiency
Fellowship guide to narcolepsy and the central disorders of hypersomnolence in children: the conditions in which the brain cannot hold a stable boundary between wakefulness and REM sleep, so the child is overwhelmed by daytime sleepiness and, in narcolepsy type 1, loses muscle tone with emotion (cataplexy). The page covers the loss of hypothalamic orexin (hypocretin) neurons that defines narcolepsy type 1, its autoimmune associations with HLA-DQB1*06:02 and the H1N1 pandemic, the split into type 1 and type 2 and the differential from idiopathic and secondary hypersomnolence, the paediatric clues of rapid weight gain, precocious puberty and cataplectic facies, the polysomnography and multiple sleep latency test that confirm it, and the layered management from scheduled naps through modafinil, stimulants, pitolisant and sodium oxybate.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- A child who buckles at the knees, drops the head or slackens the jaw when laughing, joking or surprised has cataplexy until proven otherwise, and cataplexy is nearly specific for narcolepsy type 1 — do not dismiss it as clumsiness, syncope or seizures
- New, severe daytime sleepiness that appears over weeks to months, especially with rapid weight gain or early puberty, is narcolepsy until excluded and needs a sleep study, not reassurance that the child is lazy or depressed
- Sudden-onset hypersomnolence in the months after an influenza A H1N1 infection or the Pandemrix vaccine fits post-H1N1 narcolepsy type 1 and should prompt formal assessment
- Hypersomnolence with new neurological signs, headache or focal deficits may be secondary to a hypothalamic or brainstem lesion — image the brain before settling on a primary sleep disorder
- Cataplexy can escalate to status cataplecticus, and abrupt withdrawal of an anticataplectic antidepressant can trigger it — plan medication changes, do not stop them suddenly
Life stages
Care settings
Clinical exam formats
Board mappings
- Normal sleep and its neurobiology in children
- Excessive daytime sleepiness and the sleepy child
- Central disorders of hypersomnolence
- Narcolepsy type 1 and type 2 in children
- Cataplexy recognition and management
- Pharmacological management of hypersomnolence
- The child with excessive daytime sleepiness
- Narcolepsy diagnosis with polysomnography and MSLT
- Long-term management of narcolepsy
- Long case: the adolescent with narcolepsy and its psychosocial impact
- Short case: assessment of the sleepy child
- Respiratory and sleep medicine: disorders of hypersomnolence
- The sleepy child and school failure
- Narcolepsy and cataplexy
- Assessment of the child with excessive daytime sleepiness
- Narcolepsy
- Excessive daytime sleepiness
- Sleep disorders in children
- Medical Knowledge: central disorders of hypersomnolence
- Medical Expert: narcolepsy and hypersomnolence
Overview & Definition
Picture a bright ten-year-old who was doing well at school, then over a few months becomes impossible to keep awake. He nods off in class, on the sofa and even mid-sentence, and no amount of night-time sleep fixes it. Then his parents notice something stranger: when he laughs hard his knees sag and his head drops for a second or two, and he stays fully aware throughout. This pairing of relentless daytime sleepiness with emotion-triggered loss of muscle tone is the clinical face of narcolepsy. [1] [2]
Narcolepsy is best understood as a failure of the brain to keep wakefulness and REM sleep in separate compartments. The features of REM sleep — muscle atonia and dreaming — leak into wakefulness as cataplexy, sleep paralysis and hallucinations, while the drive to stay awake collapses into irresistible sleepiness. In narcolepsy type 1 this is caused by loss of the hypothalamic neurons that make orexin (also called hypocretin), the signal that normally stabilises wakefulness and holds REM sleep at bay. [4] [3]
Hypersomnolence is the broader umbrella under which narcolepsy sits, and the fellowship task is to recognise it, prove it, and sort it. A sleepy child may have narcolepsy, idiopathic hypersomnia, or sleepiness that is secondary to something else entirely — insufficient sleep, another sleep disorder such as obstructive sleep apnoea, a medication, depression, or a neurological disease. Getting the label right matters, because narcolepsy is lifelong and specifically treatable, while secondary sleepiness is fixed by treating its cause. [1] [3]
References14ShowHide
- [1]Morse AM; Kim SY; Harris S; et al Narcolepsy: Beyond the Classic Pentad. CNS Drugs, 2025.PMID 40111737
- [2]Rocca FL; Pizza F; Ricci E; et al Narcolepsy during Childhood: An Update. Neuropediatrics, 2015.PMID 25961600
- [3]Barateau L; Pizza F; Chenini S; et al Narcolepsies, update in 2023. Rev Neurol (Paris), 2023.PMID 37634997
- [4]Rauf R; Asif S; AlSaafeen A; et al Orexin Deficiency in Narcolepsy: Molecular Mechanisms, Clinical Phenotypes, and Emerging Therapeutic Frontiers. Brain Behav, 2025.PMID 41076550
- [5]Vassalli A; Tafti M; Liblau RS Narcolepsy is (not) an autoimmune disease. Nat Rev Neurol, 2026.PMID 42321519
- [6]Ding WT; Gao JY; Guo ZL; et al Research Progress in the Roles of Influenza A H1N1 Virus and Its Vaccine in the Pathogenesis of Narcolepsy Type 1. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2025.PMID 41503654
- [7]Poli F; Pizza F; Mignot E; et al High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep, 2013.PMID 23372264
- [8]Dhanju S; Al-Saleh S; Amin R; et al A retrospective analysis of clinical characteristics of childhood narcolepsy. Paediatr Child Health, 2018.PMID 30455579
- [9]Pillen S; Pizza F; Dhondt K; et al Cataplexy and Its Mimics: Clinical Recognition and Management. Curr Treat Options Neurol, 2017.PMID 28478511
- [10]Biscarini F; Vandi S; Zenesini C; et al Use of Portable 24-Hour Polysomnography as Alternative Diagnostic Tool for Narcolepsy Type 1 in Adults and Children. Neurology, 2025.PMID 40080737
- [11]Tang SH; Min J; Zhang X; et al Incidence of pediatric narcolepsy diagnosis and management: evidence from claims data. J Clin Sleep Med, 2024.PMID 38450539
- [12]Keam SJ Pitolisant: Pediatric First Approval. Paediatr Drugs, 2023.PMID 37233887
- [13]Moresco M; Pizza F; Antelmi E; et al Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy. Curr Drug Metab, 2018.PMID 29512449
- [14]Dauvilliers Y; Lammers GJ; Lecendreux M; et al Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy. J Clin Sleep Med, 2024.PMID 37942930